eli lilly weight loss drug retatrutide Antigua Demand for Unapproved Weight-Loss Drug

Adverse events included gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones

The Accelerated Approval is based on part 1 of the ESSENCE trial that showed that at 72 weeks, 36.8% of people treated with Wegovy 2.4 mg achieved improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.4% of individuals who received placebo

Pricing Disclaimer: All pricing, bundle offers, and refund policies referenced in this article were accurate at the time of writing

See individual product page for important safety information

McCartney, M

Some states have expanded coverage to include weight management indications, while others restrict coverage to diabetes treatment only or require prior authorization